Notably, GDE2 accumulates intracellularly in AD patient neurons, and RECK release is impaired in AD postmortem brain, suggesting that the erosion of GDE2 physiological function may contribute to amyloid pathologies and behavioral changes in AD (Nakamura et al, 2021). The gene discussed is GDPD5; the disease is amyloidosis.